Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127484711 | 12748471 | 1 | I | 20160818 | 20160909 | 20160915 | 20160915 | EXP | IT-FRESENIUS KABI-FK201606588 | FRESENIUS KABI | 59.44 | YR | F | Y | 0.00000 | 20160915 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127484711 | 12748471 | 1 | PS | IRINOTECAN (Manufacturer unknown) | IRINOTECAN | 1 | Intravenous (not otherwise specified) | U | 77776 | 180 | MG | UNKNOWN | |||||||
| 127484711 | 12748471 | 2 | SS | CETUXIMAB | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 200152 | 0 | 500 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127484711 | 12748471 | 1 | Intestinal adenocarcinoma |
| 127484711 | 12748471 | 2 | Intestinal adenocarcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127484711 | 12748471 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127484711 | 12748471 | Acute kidney injury | |
| 127484711 | 12748471 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127484711 | 12748471 | 1 | 20160530 | 20160818 | 0 | |
| 127484711 | 12748471 | 2 | 20160530 | 20160818 | 0 |